OSCR
Oscar Health, Inc.
OSCR offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
WDC
Western Digital Corporation
WDC has the edge over OSCR overall, supported by stronger modeled upside and lower modeled downside.
OSCR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
OSCR's revenue, profitability, cash flow and balance sheet are all currently healthy.
WDC Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
WDC's revenue, profitability, cash flow and balance sheet are all currently strong.
OSCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $31.94 | — |
| Current | 13x | $31.94 | — |
| Cheap | 21x | $52.73 | +65% |
| Fair | 35x | $87.23 | +173% |
| Expensive | 130x | $322 | +907% |
Historical ranges are pointers, not guarantees.
OSCR has the edge over WDC in the historical PE scenario, which offers more potential upside but is not a forecast.
WDC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.9x | $255 | -18% |
| Forward | 11x | $311 | — |
| Current | 12x | $311 | — |
| Fair | 19x | $487 | +56% |
| Expensive | 63x | $1,618 | +420% |
Historical ranges are pointers, not guarantees.
WDC's PE is in its cheap range at 12x, but its recent earnings include one-off gains. If earnings grow as analysts expect, today's price would be 11x next year's earnings.
OSCR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for OSCR, with profitability improving.
WDC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
Analysts expect strong earnings and revenue growth for WDC, with profitability improving.
OSCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.61 | +5.6% |
| Q3 2026 | $2.47 | +$3.47 |
| Q2 2026 | $1.45 | +$2.14 |
| Q1 2026 | -$0.54 | -235% |
| Q4 2025 | -$1.69 | -1790% |
| Q3 2025 | -$1.00 | -$0.92 |
| Q2 2025 | -$0.69 | -$0.54 |
| Q1 2025 | $0.40 | +$0.82 |
| Q4 2024 | $0.10 | +$1.32 |
OSCR has returned to profit: it earned $2.47 per share over the past year, after losing money the year before.
WDC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $28.81 | +12% |
| Q3 2026 | $25.84 | +276% |
| Q2 2026 | $24.28 | +371% |
| Q1 2026 | $16.75 | +268% |
| Q4 2025 | $9.97 | +187% |
| Q3 2025 | $6.87 | +655% |
| Q2 2025 | $5.15 | +$7.76 |
| Q1 2025 | $4.55 | +$9.61 |
| Q4 2024 | $3.47 | +$10.69 |
WDC has the edge over OSCR on earnings, with more consistent year-over-year improvement.
OSCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +72% |
| Q2 2026 | $4.9B | +70% |
| Q1 2026 | $4.6B | +53% |
| Q4 2025 | $2.8B | +17% |
| Q3 2025 | $3B | +23% |
| Q2 2025 | $2.9B | +29% |
| Q1 2025 | $3B | +42% |
| Q4 2024 | $2.4B | +67% |
OSCR has the edge over WDC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.5% | +7.8 points |
| Q2 2026 | 8% | +16 points |
| Q1 2026 | 15% | +5.4 points |
| Q4 2025 | -12% | -5.7 points |
| Q3 2025 | -4.3% | -2.3 points |
| Q2 2025 | -8.1% | -11 points |
| Q1 2025 | 9.8% | +1.1 points |
| Q4 2024 | -6.2% | +4 points |
OSCR's operating margin was 3.5% last quarter, up 7.8 points from the same quarter a year ago.
WDC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.4B | +55% |
| Q2 2026 | $3.7B | +44% |
| Q1 2026 | $3.3B | +45% |
| Q4 2025 | $3B | -30% |
| Q3 2025 | $2.8B | -31% |
| Q2 2025 | $2.6B | -31% |
| Q1 2025 | $2.3B | -34% |
| Q4 2024 | $4.3B | +41% |
WDC's revenue is growing: $4.4B last quarter, up 55% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 47% | +19 points |
| Q2 2026 | 42% | +16 points |
| Q1 2026 | 36% | +2.5 points |
| Q4 2025 | 30% | +10 points |
| Q3 2025 | 28% | +10 points |
| Q2 2025 | 26% | +20 points |
| Q1 2025 | 33% | +25 points |
| Q4 2024 | 20% | +27 points |
WDC has the edge over OSCR on profitability, with a higher operating margin.
OSCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -$238.2M |
| Q2 2026 | $2.1B | +316% |
| Q1 2026 | $2.6B | +200% |
| Q4 2025 | $662.8M | +95% |
| Q3 2025 | -$973.7M | -$466M |
| Q2 2025 | $499.8M | +2.1% |
| Q1 2025 | $869.5M | +38% |
| Q4 2024 | $340M | +17% |
OSCR usually generates cash, though not every quarter: the latest was −$1.2B, but it generated $4.1B over the past year.
WDC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.4B | +130% |
| Q2 2026 | $1.3B | +90% |
| Q1 2026 | $978M | +158% |
| Q4 2025 | $653M | +128% |
| Q3 2025 | $599M | +$661M |
| Q2 2025 | $675M | +170% |
| Q1 2025 | $379M | +$418M |
| Q4 2024 | $287M | +$529M |
WDC has the edge over OSCR on cash flow, with more consistent year-over-year improvement.
OSCR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.9% | +13M shares |
| 1 year | +34% | +87.2M shares |
| 3 years | +55% | +123M shares |
| 5 years | +66% | +138M shares |
| Available history | +71% | +143M shares |
OSCR has 346M diluted shares, up 34% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
WDC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +1M shares |
| 1 year | +2.1% | +8M shares |
| 3 years | +19% | +61M shares |
| 5 years | +22% | +68M shares |
| Available history | +29% | +86M shares |
WDC has the edge over OSCR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1B |
| Q2 2026 | $672M |
| Q1 2026 | $752M |
| Q4 2025 | $615M |
| Q3 2025 | $553M |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
WDC spent $3B buying back its own shares over the past year.
OSCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.2x | Net Cash |
| Q2 2026 | -5.5x | Net Cash |
| Q1 2026 | -110.0x | Net Cash |
| Q1 2025 | -9.7x | Net Cash |
| Q4 2024 | -13.7x | Net Cash |
| Q3 2024 | -10.1x | Net Cash |
| Q2 2024 | -24.0x | Net Cash |
| Q1 2024 | -217.7x | Net Cash |
OSCR has the edge over WDC on leverage, with a lower net debt burden relative to earnings.
WDC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | -0.1x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 0.8x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.8x | Very low |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.9x | Healthy |
WDC has more cash than debt.
OSCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.7 | Neutral |
| Stochastic | 44.9 | Neutral |
OSCR's weekly RSI is 59 (neutral) and its Stochastic is 45 (neutral).
WDC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 11.2 | Oversold |
WDC's weekly RSI is 41 (neutral) and its Stochastic is 11 (oversold).
OSCR PE vs Healthcare Sector
| Metric | OSCR | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 26x | 50% below |
| PE % | 3 | 35 | 32 pts below |
OSCR is trading at 13x earnings, a 50% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
WDC PE vs Technology Sector
| Metric | WDC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 28x | 57% below |
| PE % | 28 | 35 | 7 pts below |
WDC has the edge over OSCR on valuation relative to its sector.
OSCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.2 | 2.3% above |
| 20 week MA | $31.1 | 2.8% above |
| 50 week MA | $22.9 | 39% above |
| 100 week MA | $19.3 | 65% above |
| 200 week MA | $15.5 | 106% above |
OSCR has the edge over WDC on trend strength, trading above more of its moving averages.
WDC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $360.8 | 14% below |
| 20 week MA | $438.4 | 29% below |
| 50 week MA | $380.4 | 18% below |
| 100 week MA | $226.8 | 37% above |
| 200 week MA | $133.7 | 133% above |
WDC has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 133% above its 200-week average.
OSCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $31.0 | $8.02 | -74% |
| 2022 | $8.02 | $2.21 | -72% |
| 2023 | $2.21 | $9.15 | +314% |
| 2024 | $9.15 | $13.8 | +51% |
| 2025 | $13.8 | $14.9 | +8% |
| 2026 YTD | $14.9 | $31.9 | +114% |
OSCR has the edge over WDC on returns for 2026, with the stronger performance.
WDC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $47.0 | $37.7 | -20% |
| 2021 | $37.7 | $46.2 | +23% |
| 2022 | $46.2 | $23.1 | -50% |
| 2023 | $23.1 | $39.6 | +71% |
| 2024 | $39.6 | $45.9 | +16% |
| 2025 | $45.9 | $181.5 | +296% |
| 2026 YTD | $181.5 | $311.2 | +71% |
WDC's yearly returns have swung widely, from +296% in 2025 to −50% in 2022. It's up 71% so far in 2026.